Andrew J Brenner

11PUBLICATIONS
89CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsRadiation therapyGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 03, 2026
Inhibition of Acetyl-CoA-carboxylase induces endoplasmic reticulum stress and augments the efficacy of anti-cancer therapies.

|Mar 07, 2025
Convection enhanced delivery of Rhenium (186Re) Obisbemeda (186RNL) in recurrent glioma: a multicenter, single arm, phase 1 clinical trial.

Andrew J Brenner, Toral Patel, Ande Bao

|Dec 18, 2024
Phase II Study of Defactinib (VS6063) in Patients With Tumors With NF2 Loss: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol U.

Marjorie G Zauderer, Opeyemi Jegede, David M Jackman

|Jul 26, 2023
Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma.

Uday P Pratap, Michael Tidwell, Henriette U Balinda

|Jun 26, 2023
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer.

Elena Shagisultanova, William Gradishar, Ursa Brown-Glaberman

|Apr 24, 2023
Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma.

William Kelly, Adolfo Enrique Diaz Duque, Joel Michalek

Pageof 2

Frequent Collaborators

2 joint publications

Yidong Chen

2 joint publications

Henriette U Balinda

1 joint publications

Benjamin M Ellingson

1 joint publications

Steven Brem